Rise, and pronounced regional variation, in methylphenidate, amphetamine, and lisdexamfetamine distribution in the United States

BACKGROUND: The prescription stimulants methylphenidate, amphetamine, and lisdexamfetamine are sympathomimetic drugs with therapeutic use. They are designated in the United States as Schedule II substances, defined by the 1970 Controlled Substances Act as having a “high potential for abuse”. Changin...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaddadi, Sneha M., Czelatka, Nicholas J., Gutierrez, Belsy D., Maddineni, Bhumika C., McCall, Kenneth L., Piper, Brian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2021
Materias:
Drugs and Devices
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706327/
https://www.ncbi.nlm.nih.gov/pubmed/35036132
http://dx.doi.org/10.7717/peerj.12619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706327/
https://www.ncbi.nlm.nih.gov/pubmed/35036132
http://dx.doi.org/10.7717/peerj.12619

Ejemplares similares